Drug intelligence / Profile preview

Luminal type-2

Development stage
Phase 2
Lead developer
The Second Hospital of Tianjin Medical University
Modality
Small Molecules, Peptides
Administration
Implant, Oral, Subcutaneous
01

Overview

Luminal type-2 is a combination therapeutic regimen evaluated in the Phase 2 STAMP clinical trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Developed by the Second Hospital of Tianjin Medical University, the regimen consists of the gonadotropin-releasing hormone (GnRH) agonist goserelin, the CYP17A1 inhibitor abiraterone, and the corticosteroid prednisone. It is specifically administered to patients identified with the luminal molecular subtype of prostate cancer who are randomized to receive this experimental androgen receptor-targeted therapy instead of standard docetaxel chemotherapy.

Other names
goserelin + abiraterone + prednisonegoserelin + abiraterone acetate + prednisonegoserelin, abiraterone, and prednisone
02

Targets

CYP17A1 (Steroid 17-alpha-hydroxylase/C17,20 lyase)GR (Glucocorticoid receptor)GnRHR (Gonadotropin-releasing hormone receptor)

Beyond the preview

Go deeper on Luminal type-2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminal type-2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call